Nigeria targets 70% local pharmaceutical production by 2030

The Nigerian government has set a strategic target to achieve 70 percent local production of essential medicines by 2030. This initiative aims to strengthen national health security and reduce vulnerability to foreign exchange volatility and global supply chain disruptions.

During the 8th Nigeria Pharma Manufacturers Expo in Lagos, Minister of State for Health and Social Welfare Iziaq Salako highlighted the Presidential Initiative to Unlock Healthcare Value Chains (PVAC). The initiative has reportedly secured $2 billion in financing at single-digit interest rates, with approximately 50 Nigerian health firms in advanced funding discussions. To support local industry, an Executive Order has introduced zero tariffs on pharmaceutical machinery, active pharmaceutical ingredients (APIs), and excipients, benefiting 87 manufacturers.

Despite these efforts, challenges remain regarding import substitution. While the number of local pharmaceutical companies has grown from fewer than 180 in 2021 to over 200, pharmaceutical import values have fluctuated, reaching $766.2 million in 2025. Industry leaders, including Fidson Healthcare Chairman Dr. Fidelis Ayebae, have emphasized that strengthening domestic manufacturing is vital for economic growth and have urged international investors, particularly from India, to establish production facilities within Nigeria to serve the wider African market.